small molecule

ISONIAZID

ISONIAZID

Loss of exclusivityloss of exclusivity
CompanyOMNIVIUM PHARMACEUTICALS LLC

Drug detail

Brand nameISONIAZID
Active ingredientISONIAZID
Strength100MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalJune 1997
Marketing statusRX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

ISONIAZID patent cliff — loss of exclusivity — | CliffBio